India's largest medical cyclotron - Cyclone-30 - is now operational, the country's Department of Atomic Energy announced yesterday. As well as producing medical radioisotopes, it will also have dedicated beamlines for material science and nuclear physics research.
 

A framework cooperation agreement has been signed between Norway's Institute for Energy Technology and Belgium's Nuclear Research Centre, through which the two organisations will extend their collaboration on nuclear research and decommissioning.

An upgraded version of India's oldest research reactor, Apsara, has been recommissioned, nine years after it was shut down, the Bhabha Atomic Research Centre has announced.

Belgium's Council of Ministers has approved EUR558 million (USD646 million) in funding for the Myrrha accelerator-driven research reactor at the Belgian Nuclear Research Centre's site in Mol.

The China Advanced Research Reactor has been operated continuously at high-power for 14 days, setting a new operational record for the 60 MWt light-water tank-in-pool type unit. The reactor has also completed its first batch of irradiation tasks.

The US Department of Energy earlier this month organised a two-day workshop to discuss the collaborative opportunities created by the permanent shutdown of the Halden nuclear fuel and materials testing reactor in Norway.

SNC-Lavalin's Candu Energy Inc is to provide decommissioning services for the Saskatchewan Research Council's (SRC) Slowpoke-2 research reactor, the company announced yesterday.

Bruce Power and ITG have launched a joint effort to explore the production of the medical radioisotope lutetium-177 at Bruce Power's Candu reactors.

The board of directors of Norway's Institute for Energy Technology has decided to close the Halden Reactor permanently and to start its decommissioning. 

The US Department of Energy's (DOE's) Office of Nuclear Energy has awarded nearly USD64 million to 89 projects for nuclear energy research, facility access and crosscutting technology and infrastructure development.

Organisational and technical measures are needed to improve the safety of the Democratic Republic of Congo's research reactor, an International Atomic Energy Agency team of experts has concluded. TRICO-II, at the Kinshasa Nuclear Research Centre (CREN-K), has not been in operation since 2003.

The High Flux Reactor at Petten in the Netherlands is now producing the medical radioisotope Xenon-133. The move follows the successful collaboration between nuclear medicine company Curium and the Nuclear Research and Consultancy Group to develop and install a production process for the isotope.